
Faron Appoints Dr. Birge Berns, MD as Interim Chief Medical Officer
• Dr. Marie-Louise Fjällskog, outgoing CMO, is proposed to continue key role in bexmarilimab’s development as a Board member Company announcement, September 21, 2023 TURKU, Finland and BOSTON, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd. ( …